DK0867436T3 - N-arylpiperidinderivater og deres anvendelse som 5-HT1B-receptorligander - Google Patents

N-arylpiperidinderivater og deres anvendelse som 5-HT1B-receptorligander

Info

Publication number
DK0867436T3
DK0867436T3 DK98400711T DK98400711T DK0867436T3 DK 0867436 T3 DK0867436 T3 DK 0867436T3 DK 98400711 T DK98400711 T DK 98400711T DK 98400711 T DK98400711 T DK 98400711T DK 0867436 T3 DK0867436 T3 DK 0867436T3
Authority
DK
Denmark
Prior art keywords
receptor ligands
aryl
ht1b receptor
arylpiperidine derivatives
alkyl
Prior art date
Application number
DK98400711T
Other languages
Danish (da)
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Alain Gobert
Valerie Audinot
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0867436T3 publication Critical patent/DK0867436T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98400711T 1997-03-27 1998-03-26 N-arylpiperidinderivater og deres anvendelse som 5-HT1B-receptorligander DK0867436T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9703760A FR2761358B1 (fr) 1997-03-27 1997-03-27 Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0867436T3 true DK0867436T3 (da) 2004-10-04

Family

ID=9505236

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98400711T DK0867436T3 (da) 1997-03-27 1998-03-26 N-arylpiperidinderivater og deres anvendelse som 5-HT1B-receptorligander

Country Status (18)

Country Link
US (1) US5965575A (zh)
EP (1) EP0867436B1 (zh)
JP (1) JPH10279578A (zh)
CN (1) CN1090628C (zh)
AT (1) ATE268767T1 (zh)
AU (1) AU731018B2 (zh)
BR (1) BR9803295A (zh)
CA (1) CA2232116C (zh)
DE (1) DE69824332T2 (zh)
DK (1) DK0867436T3 (zh)
ES (1) ES2223110T3 (zh)
FR (1) FR2761358B1 (zh)
HK (1) HK1014954A1 (zh)
NO (1) NO314628B1 (zh)
NZ (1) NZ330041A (zh)
PL (1) PL194118B1 (zh)
PT (1) PT867436E (zh)
ZA (1) ZA982607B (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782515B1 (fr) * 1998-08-21 2000-09-22 Adir NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
EP1146871A4 (en) * 1999-01-28 2002-04-17 Bristol Myers Squibb Co HETEROCYCLIC ANTIDEPRESSANT COMPOUNDS
ATE257834T1 (de) * 1999-06-30 2004-01-15 Bristol Myers Squibb Co Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
EP1353915A2 (en) * 2001-01-16 2003-10-22 AstraZeneca AB Therapeutic chroman compounds
IL156595A0 (en) 2001-01-16 2004-01-04 Astrazeneca Ab Therapeutic heterocyclic compounds
WO2002069973A1 (en) * 2001-03-02 2002-09-12 Sepracor, Inc. Piperidine-piperazine ligand for neurotransmitter receptors
SE0103836D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
UA86591C2 (ru) * 2003-06-30 2009-05-12 Алтана Фарма Аг Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
CA2530114A1 (en) * 2003-06-30 2005-01-13 Altana Pharma Ag Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
US7365215B2 (en) 2003-07-14 2008-04-29 Ube Industries, Ltd. Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
US20060085924A1 (en) * 2004-10-13 2006-04-27 Gaelle Brun Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer
JP2008526817A (ja) * 2005-01-12 2008-07-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規のピロロジヒドロイソキノリン
EP1838707B1 (en) * 2005-01-12 2009-04-29 Nycomed GmbH Novel pyrrolodihydroisoquinolines as pde10 inhibitors
US8599822B2 (en) * 2005-03-23 2013-12-03 Cisco Technology, Inc. Slot-based transmission synchronization mechanism in wireless mesh networks
FR2884251B1 (fr) * 2005-04-08 2007-07-13 Servier Lab Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
CA2651732C (en) 2006-05-18 2014-10-14 Mannkind Corporation Intracellular kinase inhibitors
CA2680761A1 (en) 2007-03-22 2008-09-25 Astrazeneca Ab Quinoline derivatives for the treatment of inflammatory diseases
US8106073B2 (en) 2007-11-30 2012-01-31 Astrazeneca Ab Quinoline derivatives 057
TW200944523A (en) * 2008-02-08 2009-11-01 Organon Nv (Dihydro)pyrrolo[2,1-a]isoquinolines
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CA2232116C (fr) 2003-09-16
CN1197072A (zh) 1998-10-28
DE69824332D1 (de) 2004-07-15
HK1014954A1 (en) 1999-10-08
AU5967798A (en) 1998-10-01
NZ330041A (en) 1999-01-28
EP0867436A1 (fr) 1998-09-30
EP0867436B1 (fr) 2004-06-09
PT867436E (pt) 2004-09-30
DE69824332T2 (de) 2005-06-16
FR2761358B1 (fr) 1999-05-07
US5965575A (en) 1999-10-12
NO314628B1 (no) 2003-04-22
ES2223110T3 (es) 2005-02-16
ZA982607B (en) 1998-09-30
PL325575A1 (en) 1998-09-28
AU731018B2 (en) 2001-03-22
CN1090628C (zh) 2002-09-11
JPH10279578A (ja) 1998-10-20
CA2232116A1 (fr) 1998-09-27
BR9803295A (pt) 2000-03-21
NO981415L (no) 1998-09-28
PL194118B1 (pl) 2007-04-30
ATE268767T1 (de) 2004-06-15
FR2761358A1 (fr) 1998-10-02
NO981415D0 (no) 1998-03-27

Similar Documents

Publication Publication Date Title
DK0867436T3 (da) N-arylpiperidinderivater og deres anvendelse som 5-HT1B-receptorligander
NO20002169D0 (no) Nye pyridazinderivater og medikamenter inneholdende disse som effektive ingredienser
DE69211182D1 (de) Pyranylcyanoguanidinderivate
DK0778277T3 (da) Substituerede heterocycliske derivater som CRF antagonister
NO905306L (no) Spirocykliske forbindelser som inneholder nitrogen.
DK0457686T3 (da) Hidtil ukendte aminopiperidin-, aminopyrrolidin- og aminoperhydroazepinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO953052L (no) Nye pyrrolokarbazoler
NO913087D0 (no) Ny tricyklisk forbindelse eller salter derav, fremgangsmaate for fremstilling derav og antimikrobielt middel inneholdende slike.
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
DK0861837T3 (da) Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK0979822T3 (da) Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner
HUP9800687A1 (hu) N-aril-piperidin-származékok, eljárás előállításukra, és e vegyületeket tartalmazó gyógyszerkészítmények
DK0661273T3 (da) Indanderivater og fremgangsmåder til fremstilling af samme
NO972942D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
DK0421668T3 (da) 1,4-dihydro-4-oxo-3-quinolinderivater som selektivt toksiske, antibakterielle midler til pattedyr
NO983602D0 (no) Nye bis-pyrido£4,3-b|karbazolforbindelser, en fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger som inneholder disse
DK0573360T3 (da) Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister